[HTML][HTML] Molecular classification and therapeutic targets in ependymoma

T Larrew, BF Saway, SR Lowe, A Olar - Cancers, 2021 - mdpi.com
Simple Summary Molecular characterization of ependymoma has revolutionized its
categorization. This new molecular classification has implications particularly in targeted …

Clinical features and surgical outcomes of intracranial and spinal cord subependymomas

J Rincon-Torroella, M Rakovec, AM Khalafallah… - Journal of …, 2022 - thejns.org
OBJECTIVE Subependymomas are low-grade ependymal tumors whose clinical
characteristics, radiographic features, and postsurgical outcomes are incompletely …

Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging

M Pagès, KW Pajtler, S Puget, D Castel… - Brain …, 2019 - Wiley Online Library
Ependymoma with RELA fusion has been defined as a novel entity of the revised World
Health Organization 2016 classification of tumors of the central nervous system (CNS) …

Relative survival after diagnosis with a primary brain or other central nervous system tumor in the National Program of Cancer Registries, 2004 to 2014

QT Ostrom, G Truitt, H Gittleman, DJ Brat… - Neuro-oncology …, 2020 - academic.oup.com
Background The majority of reported cancer survival statistics in the United States are
generated using the National Cancer Institute's publicly available Surveillance …

Intracranial ependymomas: molecular insights and translation to treatment

A Lester, KL McDonald - Brain Pathology, 2020 - Wiley Online Library
Ependymomas are primary central nervous system tumors (CNS), arising within the
posterior fossa and supratentorial regions of the brain, and in the spine. Over the last …

[HTML][HTML] Surgical management and long-term outcome of intracranial subependymoma

A Varma, D Giraldi, S Mills, AR Brodbelt… - Acta …, 2018 - Springer
Background Intracranial subependymomas account for 0.2–0.7% of central nervous system
tumours and are classified as World Health Organization (WHO) grade 1 tumours. They are …

[HTML][HTML] Intracranial hemangioblastoma–A SEER-based analysis 2004–2013

HS Nguyen, NB Doan, M Gelsomino, S Shabani… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Methods With the SEER-18 registry database, information from all patients diagnosed with
intracranial HB from 2004 to 2013 were extracted, including age, gender, race, marital …

[HTML][HTML] Tumor characteristics and surgical outcomes of intracranial subependymomas: a systematic review and meta-analysis

BTS Kweh, JV Rosenfeld, M Hunn, JW Tee - Journal of Neurosurgery, 2021 - thejns.org
OBJECTIVE The tumor characteristics and surgical outcomes of intracranial
subependymomas are poorly defined. In this study the authors aimed to provide a …

Dysembryoplastic neuroectodermal tumor: an analysis from the surveillance, epidemiology, and end results program, 2004–2013

HS Nguyen, N Doan, M Gelsomino, S Shabani - World neurosurgery, 2017 - Elsevier
Background Dysembryoplastic neuroectodermal tumor (DNT) is a rare neoplasm. Though
the pathology is commonly considered benign, there have been various reports …

Ependymal Tumors: Overview of the Recent World Health Organization Histopathologic and Genetic Updates with an Imaging Characteristic

N Soni, M Ora, G Bathla, A Desai… - American Journal of …, 2024 - Am Soc Neuroradiology
The 2021 World Health Organization Classification of Tumors of the Central Nervous System
(CNS5), introduced significant changes, impacting tumors ranging from glial to ependymal …